65,437 trials
Acute Lymphoblastic Leukemia · Brain Tumors
Primary: Brain White Matter Volume for Patients Versus Sibling Controls — 27; 30.3 percentage — p=<.0001
Infection
Primary: Endometritis and Wound Infection — 6; 4 patients infected
Healthy
Primary: Lopinavir Pharmacokinetics When Administered Alone and in Combination With Three Different Herbal Supplements: Ginkgo Biloba, Panax Ginsing, and Echinacea Purpurea…
Arthritis, Psoriatic
Primary: American College of Rheumatology (ACR) 20 Response at Week 14 — 10; 74; 66; 140 Participants — p=<0.001
Contact Lens Moisture
Primary: Mean Ex-Vivo Advancing Contact Angle — 56.7; 59.2 Degrees
Cognitive Function · Mood
Primary: Modulation of Levels of Total Haemoglobin — -1.4; -1.3; -1.7 μmol/L — p=<0.05
Status Epilepticus
Primary: Number of Subjects With Termination of Seizures at ED Arrival With no Rescue Therapy Given — 329; 282 participants — p=<0.001
Smoking Cessation · Alcohol Consumption
Primary: Number of Smoke-free Patients — 0; 3 participants — p==.111
Contact Lens Wettability
Primary: Lens Wettability — 95.5; 97.0 percentage of lenses
Recurrent Prostate Cancer · Stage I Prostate Cancer · Stage IIA Prostate Cancer
Primary: Number of Patients With PSA Response, Defined as a 50% or Greater Decline in the Serum PSA Level — 0; 28; 4; 3 participants
Diabetes Mellitus, Type 2
Primary: Change From Baseline in Glycosylated Hemoglobin (HbA1c) at 6-Month Endpoint — -0.08; 0.06; -0.15; 0.04 percent glycosylated hemoglobin (HbA1c) — p=0.623
Advanced Solid Tumor
Primary: Mean Time-matched, Baseline Corrected QTcF at Any Time Point Postdosing. — 2; 11 msec
Type 1 Diabetes
Primary: Number of Participants With a 2-step or Greater Increase in Early Treatment Diabetic Retinopathy Study (ETDRS) Severity Scale. — 178; 217 Participants — p=0.0508
Autism
Primary: Number of Participants With the Given Clinical Global Impression Scale - Improvement (CGI-I) Score — 5; 5; 10 participants
Conjunctival Staining
Primary: Conjunctival Staining at 1 Minute — 3.29; 3.67; 3.98 Units on a scale